cGvHD

What is new in chronic GvHD?

L: English

The GvHD Hub are proud to present expert interviews directly from the 61st American Society of Hematology (ASH) meeting in Orlando, US. This interview with Steven Pavletic, National Cancer Institute, Bethesda, US, was based on the question: What is new in chronic graft-versus-host disease?

Steven Pavletic gives a comprehensive overview of the evolving field of chronic GvHD. He also discusses clinical trials, FDA approvals and novel interventions for the prevention and treatment of GvHD.

Was this article informative? Thank you for your feedback!